CD8A and cancer: IL-2 controls essential cytolytic effector and metabolic programs in CTL, is a key cytokine for CD8 T cell anti-viral immunity and is also used to produce cytotoxic T cells for anti-cancer immunotherapy (Kalia and Sarkar, 2018).